Advertisement

Topics

Cerus Company Profile

06:46 EDT 21st June 2018 | BioPortfolio

At Cerus Corporation we have developed a platform technology (Helinx®) that prevents nucleic acid (DNA and RNA) replication. The Company's initial application of this technology is the development of the INTERCEPT Blood Systems to inactivate viruses, bacteria and other pathogens in the blood components used for transfusion - platelets, plasma and red blood cells.

Location

2411 Stanwell Drive
Concord
CA
94520
United States of America

Contact

Phone: (925) 288-6000
Fax: (925) 288-6001
Email: customer_services@cerus.com


News Articles [29 Associated News Articles listed on BioPortfolio]

Cerus gains $15M from contract amendment to support blood transfusion studies

An expanded agreement between HHS' Biomedical Advanced Research and Development Authority and Cerus will provide an additiona -More- 

Cerus to Present at the Cowen and Company 38th Annual Health Care Conference on March 13, 2018

Cerus Corporation (NASDAQ: CERS) announced today that William ‘Obi’ Greenman, Cerus’ president and chief executive officer, is scheduled to present a corporate update at the...

Cerus nets $49.7mm through public offering

Cerus Corp. (blood transfusion safety devices) netted $49.7mm through a public sale of 12.2mm common shares at $4.10. Proceeds will support ongoing development and commercialization of the Intercept p...

Cerus to Present at the Deutsche Bank 43rd Annual Health Care Conference on Wednesday May 9, 2018

Cerus Corporation (Nasdaq: CERS) announced today that Dr. Laurence M. Corash, co-founder and chief scientific officer, and Lainie Corten, vice president of global marketing, are s...

Cerus nets $57.2mm through public offering

Cerus Corp. (blood transfusion safety devices) netted $57.2mm through a public sale of 14mm common shares (including the overallotment) at $4.10. Proceeds will support ongoing development and commerci...

Cerus to Release First Quarter 2018 Results on May 8, 2018

Cerus Corporation (Nasdaq:CERS) announced today that its first quarter results will be released on Tuesday, May 8, 2018, after the close of the stock market. The company will host...

Cerus to Release Fourth Quarter and Year End 2017 Results on March 8, 2018

Cerus Corporation (NASDAQ:CERS) announced today that its fourth quarter and year end results for 2017 will be released on Thursday, March 8, 2018, after the close of the stock mar...

Health Canada approves Cerus’ Intercept blood system for platelets

Cerus announced that Health Canada has approved the commercialization of Intercept blood system for platelets.

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Synthesis, antibacterial activity, synergistic effect, cytotoxicity, docking and molecular dynamics of benzimidazole analogues.

A series of 2-Cl-benzimidazole derivatives was synthesized and assessed for antibacterial activity. Antibacterial results indicated that compounds 2d, 2e, 3a, 3b, 3c, 4d and 4e showed promising activi...

Molecular modeling, synthesis, antibacterial and cytotoxicity evaluation of sulfonamide derivatives of benzimidazole, indazole, benzothiazole and thiazole.

A new series of heterocyclic molecules bearing sulfonamide linkage has been synthesized and screened for antibacterial activity. During antibacterial screening using broath dilution method, molecules ...

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Cerus

At Cerus Corporation we have developed a platform technology (Helinx®) that prevents nucleic acid (DNA and RNA) replication. The Company's initial application of this technology is the development o...

Cerus Corporation and SunCoast Blood Bank

Cerus Corporation

Condensed Consolidated Unaudited Balance Sheets

More Information about "Cerus" on BioPortfolio

We have published hundreds of Cerus news stories on BioPortfolio along with dozens of Cerus Clinical Trials and PubMed Articles about Cerus for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cerus Companies in our database. You can also find out about relevant Cerus Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...


Corporate Database Quicklinks



Searches Linking to this Company Record